Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: A multi-center study in China

被引:92
作者
Lu, Ming-De
Yu, Xiao-Ling
Li, An-Hua
Jiang, Tian-An
Chen, Min-Hua
Zhao, Bao-Zhen
Zhou, Xiao-Dong
Wang, Jin-Rui
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] PLA, Gen Hosp, Beijing, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[5] Peking Univ, Sch Oncol, Beijing, Peoples R China
[6] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China
[7] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China
[8] Peking Univ, Hosp 3, Beijing, Peoples R China
关键词
hepatocellular carcinoma; percutaneous thermal ablation; contrast-enhanced US;
D O I
10.1016/j.ultrasmedbio.2007.05.004
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
To evaluate the ability of contrast enhanced ultrasound (CEUS) in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma (HCC) in comparison with contrast enhanced computed tomography (CECT) and/or magnetic resonance imaging (CEMRI). A total of 151 patients were enrolled in the study. Before the radio-frequency (RF) or microwave ablation treatment, tumor vascularity was assessed in 139 patients with three imaging modalities i.e., US (139 exams), CEUS (139 exams) and CECT (103 exams)/CEMR (36 exams). CEUS examination was performed using a sulphur hexafluoride-filled microbubble contrast agent (SonoVue (R), Bracco, Milan, Italy) and real-time contrast-specific imaging techniques. Within 30 +/- 7 d after the ablation procedure, 118/139 patients were monitored to assess the tumor response to treatment. Before ablation, contrast enhancement within tumor was observed in 129/139 (92.8%) patients with CEUS and 133/139 (95.7%) patients with CECT/CEMRI. Compared with CECT/CEMRI, CEUS sensitivity and accuracy in detecting tumor vascularity were 97.0% and 94.2%, respectively. One month after treatment, no enhancement was seen in 110/118 (93.2%) both on CEUS and CECT/CEMRI. Concordance between CEUS and CECT/CEMR on the presence of residual vascularization was obtained in four patients (true positive). The specificity and accuracy of CEUS in detecting tumor vascularity were 98.2% and 96.6%, respectively. The periprocedural impact of SonoVue administration on the assessment of treatment extent was also evaluated in a subgroup of patients and CEUS showed its superiority compared with baseline US in defining treatment outcome. In conclusion, in the detection of HCC tumor vascularity and assessment of response to thermal ablation after 1 month, real time CEUS provided results comparable to those obtained with CECT/CEMRI. CEUS examination proved to be a safe and easy to access procedure, with potential for diagnostic impact in the clinical practice. (E-mail: lumd@21cn.com) (c) 2007 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:1736 / 1749
页数:14
相关论文
共 50 条
  • [31] Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma
    Shu-Guang Zheng
    Hui-Xiong Xu
    Ming-De Lu
    Xiao-Yan Xie
    Zuo-Feng Xu
    Guang-Jian Liu
    Lin-Na Liu
    World Journal of Gastroenterology, 2013, (06) : 855 - 865
  • [32] Contrast-enhanced ultrasonography guidance avoids US-CT/MR fusion error for percutaneous radiofrequency ablation of hepatocellular carcinoma
    Lu, Yang-Bor
    Huang, Yung-Ning
    Weng, Yu-Chieh
    Chiang, Tung-Ying
    Fang, Ta-Kai
    Chen, Wei-Ting
    Lee, Jung-Chieh
    BMC MEDICAL IMAGING, 2024, 24 (01):
  • [33] Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma
    Munoz, Nina M.
    Minhaj, Adeeb A.
    Maldonado, Kiersten L.
    Kingsley, Charles, V
    Cortes, Andrea C.
    Taghavi, Houra
    Polak, Urszula
    Mitchell, Jennifer M.
    Ensor, Joe E.
    Bankson, James A.
    Rashid, Asif
    Avritscher, Rony
    MAGNETIC RESONANCE IMAGING, 2019, 57 : 156 - 164
  • [34] Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound
    Kim, Eui Joo
    Kim, Yun Soo
    Shin, Seung Kak
    Kwon, Oh Sang
    Choi, Duck Joo
    Kim, Ju Hyun
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 (06) : 446 - 452
  • [35] Contrast-enhanced CT radiomics for preoperative evaluation of microvascular invasion in hepatocellular carcinoma: A two-center study
    Zhang, Xiuming
    Ruan, Shijian
    Xiao, Wenbo
    Shao, Jiayuan
    Tian, Wuwei
    Liu, Weihai
    Zhang, Zhao
    Wan, Dalong
    Huang, Jiacheng
    Huang, Qiang
    Yang, Yunjun
    Yang, Hanjin
    Ding, Yong
    Liang, Wenjie
    Bai, Xueli
    Liang, Tingbo
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02):
  • [36] Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study
    Han, Xue
    Dong, Jing
    Liu, Zhao
    Wu, Bolin
    Tian, Yuhang
    Tan, Haoyan
    Cheng, Wen
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2020, 37 (01) : 1066 - 1073
  • [37] Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma
    Numata, Kazushi
    Fukuda, Hiroyuki
    Morimoto, Manabu
    Kondo, Masaaki
    Nozaki, Akito
    Oshima, Takashi
    Okada, Masahiro
    Takebayashi, Shigeo
    Maeda, Shin
    Tanaka, Katsuaki
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (10) : 2746 - 2753
  • [38] Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma
    Pompili, M
    Riccardi, L
    Covino, M
    Barbaro, B
    Di Stasi, C
    Orefice, R
    Gasbarrini, G
    Rapaccini, GL
    LIVER INTERNATIONAL, 2005, 25 (05) : 954 - 961
  • [39] Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria
    Kang, Hyo-Jin
    Lee, Jeong Min
    Yoon, Jeong Hee
    Yoo, Jeongin
    Kim, Jung Hoon
    Park, Jiwon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 222 (02)
  • [40] Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study
    Bartos, Adrian
    Bartos, Dana
    Sparchez, Zeno
    Iancu, Ioana
    Ciobanu, Lidia
    Iancu, Cornel
    Breazu, Caius
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (04) : 457 - 462